US 7888498
Compositions and methods for inhibiting expression of IKK-B gene
granted A61PA61P29/00
Quick answer
US patent 7888498 (Compositions and methods for inhibiting expression of IKK-B gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P29/00